Outcomes of patients with unresectable or metastatic melanoma after cessation of immunotherapy following complete response or toxicities

被引：0
|
作者：
Zulkifli, N. S. [1 ]
Tam, L. [1 ]
Mclean, A. [1 ]
Atkinson, V. G. [1 ]
机构：
[1] Princess Alexandra Hosp, Metro South Hlth, Dept Med Oncol, Woolloongabba, Qld, Australia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2242
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1108P
引用
收藏
页码：S668 / S668
页数：1
相关论文
共 50 条
  • [31] Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up
    Gutkin, Paulina M.
    Hiniker, Susan M.
    Swetter, Susan M.
    Reddy, Sunil A.
    Knox, Susan J.
    CUREUS, 2018, 10 (12):
  • [32] BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response
    Ribero, Simone
    Malavenda, Ottavia
    Fava, Paolo
    Astrua, Chiara
    Marra, Elena
    Osella-Abate, Simona
    Sanlorenzo, Martina
    Caliendo, Virginia
    Fierro, Maria Teresa
    Quaglino, Pietro
    FUTURE ONCOLOGY, 2019, 15 (02) : 133 - 139
  • [33] Recurrence of metastatic Merkel carcinoma after cessation of avelumab in a patient previously with a complete response
    Picard-Gauci, Alexandra
    Troin, Laura
    Chassang, Madleen
    Passeron, Thierry
    Montaudie, Henri
    JEADV CLINICAL PRACTICE, 2022, 1 (02): : 129 - 131
  • [34] Complete Remission of metastatic Melanoma under Therapy with Trametinib after Treatment Failure of Immunotherapy with Pembrolizumab
    Wahl, R.
    Ruebben, A.
    Amir, Y.
    Cacchi, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 70 - 70
  • [35] Complete response in a patient with a metastatic cutaneous melanoma
    Bermejo-Perez, M. J.
    Villar-Chamorro, E.
    Lemos-Simosomo, M.
    Garcia-Gonzalez, C.
    Galeote-Miguel, A. M.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2011, 34 (02) : 307 - 310
  • [36] Complete response to pembrolizumab after initial progress in a patient with metastatic uveal melanoma
    Stauner, Camila Toledo
    Drexler, Konstantin
    Berneburg, Mark
    Haferkamp, Sebastian
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (11): : 1376 - 1378
  • [37] Complete Response to Temozolomide in Metastatic Melanoma After Failure of 5 Lines of Treatment
    Magge, Tara
    Shaikh, Hira
    Chaudhary, Rekha
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (06) : E767 - E769
  • [38] ASO Author Reflections: Mixed Response in Metastatic Melanoma Patients Treated with Immunotherapy
    Rauwerdink, Daan Jan Willem
    Boland, Genevieve Marie
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (09) : 3498 - 3499
  • [39] Predictive factors of response in patients with metastatic melanoma treated with chemo-immunotherapy.
    Ortega, E
    Andres, R
    Mayordomo, JI
    Polo, E
    Lara, R
    Lastra, R
    Lambea, J
    Escudero, P
    Isla, D
    Tres, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 726S - 726S
  • [40] RARE IMMUNE SUBSETS AS BIOMARKERS FOR IMMUNOTHERAPY TREATMENT RESPONSE IN METASTATIC MELANOMA PATIENTS
    Graves, Moira
    Tang, Denise
    van der Westhuizen, Andre
    Bowden, Nikola
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 32 - 33
12345